RESUMO
Native highlanders (e.g. Sherpa) demonstrate remarkable hypoxic tolerance, possibly secondary to higher levels of circulating nitric oxide (NO) and increased microcirculatory blood flow. As part of the Xtreme Alps study (a randomised placebo-controlled trial of dietary nitrate supplementation under field conditions of hypobaric hypoxia), we investigated whether dietary supplementation with nitrate could improve NO availability and microvascular blood flow in lowlanders. Plasma measurements of nitrate, nitrite and nitroso species were performed together with measurements of sublingual (sidestream dark-field camera) and forearm blood flow (venous occlusion plethysmography) in 28 healthy adult volunteers resident at 4559â¯m for 1 week; half receiving a beetroot-based high-nitrate supplement and half receiving an identically-tasting low nitrate 'placebo'. Dietary supplementation increased plasma nitrate concentrations 4-fold compared to the placebo group, both at sea level (SL; 19.2 vs 76.9⯵M) and at day 5 (D5) of high altitude (22.9 vs 84.3⯵M, pâ¯<â¯0.001). Dietary nitrate supplementation also significantly increased both plasma nitrite (0.78 vs. 0.86⯵M SL, 0.31 vs. 0.41⯵M D5, pâ¯=â¯0.03) and total nitroso product (11.3 vs. 19.7â¯nM SL, 9.7 vs. 12.3â¯nM D5, pâ¯<â¯0.001) levels both at sea level and at 4559â¯m. However, plasma nitrite concentrations were more than 50% lower at 4559â¯m compared to sea level in both treatment groups. Despite these significant changes, dietary nitrate supplementation had no effect on any measured read-outs of sublingual or forearm blood flow, even when environmental hypoxia was experimentally reversed using supplemental oxygen. In conclusion, dietary nitrate supplementation does not improve microcirculatory function at 4559â¯m.
Assuntos
Microcirculação/fisiologia , Nitratos/sangue , Adulto , Doença da Altitude/fisiopatologia , Velocidade do Fluxo Sanguíneo , Suplementos Nutricionais , Feminino , Humanos , Masculino , Nitratos/administração & dosagem , Nitratos/metabolismo , Nitritos/sangue , Compostos Nitrosos/sangue , Adulto JovemRESUMO
Nitric oxide (NO) production plays a central role in conferring tolerance to hypoxia. Tibetan highlanders, successful high-altitude dwellers for millennia, have higher circulating nitrate and exhaled NO (ENO) levels than native lowlanders. Since nitrate itself can reduce the oxygen cost of exercise in normoxia it may confer additional benefits at high altitude. Xtreme Alps was a double-blinded randomised placebo-controlled trial to investigate how dietary nitrate supplementation affects physiological responses to hypoxia in 28 healthy adult volunteers resident at 4559â¯m for 1 week; 14 receiving a beetroot-based high-nitrate supplement and 14 receiving a low-nitrate 'placebo' of matching appearance/taste. ENO, vital signs and acute mountain sickness (AMS) severity were recorded at sea level (SL) and daily at altitude. Moreover, standard spirometric values were recorded, and saliva and exhaled breath condensate (EBC) collected. There was no significant difference in resting cardiorespiratory variables, peripheral oxygen saturation or AMS score with nitrate supplementation at SL or altitude. Median ENO levels increased from 1.5/3.0â¯â¯mPa at SL, to 3.5/7.4â¯mPa after 5 days at altitude (D5) in the low and high-nitrate groups, respectively (pâ¯=â¯0.02). EBC nitrite also rose significantly with dietary nitrate (pâ¯=â¯0.004), 1.7-5.1â¯â¯µMâ¯at SL and 1.6-6.3⯵Mâ¯at D5, and this rise appeared to be associated with increased levels of ENO. However, no significant changes occurred to levels of EBC nitrate or nitrosation products (RXNO). Median salivary nitrite/nitrate concentrations increased from 56.5/786⯵M to 333/5,194â¯â¯µM⯠with nitrate supplementation at SL, and changed to 85.6/641⯵M and 341/4,553⯵M on D5. Salivary RXNO rose markedly with treatment at SL from 0.55⯵M to 5.70⯵M. At D5 placebo salivary RXNO had increased to 1.90⯵M whilst treatment RXNO decreased to 3.26⯵M. There was no association with changes in any observation variables or AMS score. In conclusion, dietary nitrate supplementation is well tolerated at altitude and significantly increases pulmonary NO availability and both salivary and EBC NO metabolite concentrations. Surprisingly, this is not associated with changes in hemodynamics, oxygen saturation or AMS development.
Assuntos
Doença da Altitude/prevenção & controle , Suplementos Nutricionais , Pulmão/fisiologia , Nitratos/uso terapêutico , Adulto , Beta vulgaris , Feminino , Sucos de Frutas e Vegetais , Humanos , Masculino , Nitratos/administração & dosagem , Nitratos/análise , Nitratos/metabolismo , Óxido Nítrico/análise , Óxido Nítrico/metabolismo , Nitritos/análise , Nitritos/metabolismo , Oxigênio/sangue , Taxa Respiratória/fisiologia , Saliva/metabolismoRESUMO
Introduction: Nitrate supplementation in the form of beetroot juice (BRJ) ingestion has been shown to improve exercise tolerance during acute hypoxia, but its effect on exercise physiology remains unstudied during sustained terrestrial high altitude exposure. We hypothesized that performing exercise at high altitude would lower circulating nitrate and nitrite levels and that BRJ ingestion would reverse this phenomenon while concomitantly improving key determinants of aerobic exercise performance. Methods: Twenty seven healthy volunteers (21 male) underwent a series of exercise tests at sea level (SL, London, 75 m) and again after 5-8 days at high altitude (HA, Capanna Regina Margherita or "Margherita Hut," 4,559 m). Using a double-blind protocol, participants were randomized to consume a beetroot/fruit juice beverage (three doses per day) with high levels of nitrate (â¼0.18 mmol/kg/day) or a nitrate-depleted placebo (â¼11.5 µmoles/kg/day) control drink, from 3 days prior to the exercise trials until completion. Submaximal constant work rate cycle tests were performed to determine exercise efficiency and a maximal incremental ramp exercise test was undertaken to measure aerobic capacity, using breath-by-breath pulmonary gas exchange measurements throughout. Concentrations of nitrate, nitrite and nitrosation products were quantified in plasma samples collected at 5 timepoints during the constant work rate tests. Linear mixed modeling was used to analyze data. Results: At both SL and HA, plasma nitrate concentrations were elevated in the nitrate supplementation group compared to placebo (P < 0.001) but did not change throughout increasing exercise work rate. Delta exercise efficiency was not altered by altitude exposure (P = 0.072) or nitrate supplementation (P = 0.836). VÌO2peak decreased by 24% at high altitude (P < 0.001) and was lower in the nitrate-supplemented group at both sea level and high altitude compared to placebo (P = 0.041). Dietary nitrate supplementation did not alter other peak exercise variables or oxygen consumption at anaerobic threshold. Circulating nitrite and S-nitrosothiol levels unexpectedly rose in a few individuals right after cessation of exercise at high altitude. Conclusion: Whilst regularly consumed during an 8 days expedition to terrestrial high altitude, nitrate supplementation did not alter exercise efficiency and other exercise physiological variables, except decreasing VÌO2peak. These results and those of others question the practical utility of BRJ consumption during prolonged altitude exposure.